VAXIM INC has a total of 11 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are YUEYANG XINHUA PHARMACEUTICAL CO LTD, GANSOW OTTO A and DA LIDAXUE.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 4 | |
#3 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Sugars | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Analysing materials | |
#7 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Chu Yong Liang | 11 |
#2 | Qiu Jian-Tai | 8 |
#3 | Li Frank Q | 7 |
#4 | Lai Wan-Ching | 7 |
#5 | Li Franck Q | 4 |
#6 | Lin Jerry | 2 |
#7 | Zhu Shuren | 1 |
Publication | Filing date | Title |
---|---|---|
WO2005018538A2 | Severe acute respiratory syndrome (sars) polypeptides, antibodies to sars polypeptides and the use thereof in diagnostic, vaccination and therapeutic applications | |
WO2004060284A2 | Method of using colloidal metal-protein composition for treatment of cancer | |
WO03066096A1 | Polymeric conjugates for delivery of mhc-recognized epitopes via peptide vaccines | |
AU2003201826A8 | Compounds for delivering substances into cells | |
US6809191B2 | GM-CSF nucleic acid sequences | |
US7314956B2 | Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cell |